Table:
begin	end	state
1	29	cytoplasmic
30	33	non-cytoplasmic
34	46	transmembrane
47	61	non-cytoplasmic
62	81	transmembrane
82	92	cytoplasmic
93	111	transmembrane
112	116	non-cytoplasmic
117	138	transmembrane
139	158	cytoplasmic
159	181	transmembrane
182	192	non-cytoplasmic
193	212	transmembrane
213	251	cytoplasmic
252	271	transmembrane
272	290	non-cytoplasmic
291	310	transmembrane
311	318	cytoplasmic
319	339	transmembrane
340	344	non-cytoplasmic
345	368	transmembrane
369	378	cytoplasmic
379	401	transmembrane
402	412	non-cytoplasmic
413	432	transmembrane
433	464	cytoplasmic

Input:
>WP_058930128.1 NCBI__GCF_001484605.1:WP_058930128.1
MSTQQAEVQSEAAQTRRAVSNILKGSAGNLVEWYDLYVYTVFAAYFQSHFFNSQDDLQAG
LEAMAVFSTSFLMRPVGAWFFGRYADRKGRKAALTLSVTIMSAGSFAIAILPTTQQIGVW
ALILLILVRLVQGFSVGGEYGTSATYMSEAATSKRRGFFSSFQYVTLIGGQMLALLVLVI
LQNTMDKGALTEWGWRIPFAIGGVAALVVLWLRRSMEETVSAEQVEAAKVPAVAGVAQPG
TMKLLFTQHWKPLLICIGVTLGGTVAFYTYTNFILKFMNDTSGIAKTDTSVINFWALFIF
MLLQPVYGIISDKVGRRPLLLWFGITGVLFTWPLLSTLAGTKDPFTAFLLMLGGLLIVGG
YTSINALVKAELFPASIRALGVGLGYAIANSLFGGTVPLLGAAFQKAERVDLFFTYVTVA
IAISLVVYIFALKNKKATHLDREQGDAWNRPAKDDDKDKDLINA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server